Targeting ASCT2‐mediated glutamine uptake blocks prostate cancer growth and tumour development

Overview of attention for article published in The Journal of Pathology, April 2015

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (87th percentile)
High Attention Score compared to outputs of the same age and source (85th percentile)

Mentioned by

twitter: 4 X users
patent: 8 patents

guideline: 1 clinical guideline source

Readers on

mendeley: 186 Mendeley
citeulike: 1 CiteULike

So far, Altmetric has seen 8 patents that reference this research output.

TREATMENT OF ASCT2-DEPENDENT CANCERS

Application WO-2024107753-A3

World Intellectual Property Organisation (WIPO)

27 Jun 2024

Anticancer therapeutic intervention

Grant US-11319541-B2

United States of America

03 May 2022

DIBENZYLAMINES AS AMINO ACID TRANSPORT INHIBITORS

Application WO-2020252336-A1

World Intellectual Property Organisation (WIPO)

17 Dec 2020

AMINO ACID TRANSPORT INHIBITORS AND THE USES THEREOF

Application WO-2020252353-A1

World Intellectual Property Organisation (WIPO)

17 Dec 2020

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 4 additional patents.